• linkedin
  • Increase Font
  • Sharebar

    MRI-guided PCa detection strategies found cost-effective

    Diagnostic magnetic resonance imaging (MRI) strategies for the diagnosis of prostate cancer should be considered prior to biopsy of suspicious lesions, according to the results of a study published online in Radiology (2017 May 17:162181).

    Compared with transrectal ultrasound-guided biopsies, MRI diagnostic exams followed by MRI-guided biopsies yielded net health benefits well within the commonly accepted threshold for cost-benefit ratios.

    “We believe that the adoption of these strategies could be very beneficial to the patient and the health care system,” Vikas Gulani, MD, PhD, of University Hospitals Case Medical Center, Cleveland, told Urology Times on behalf of him and his partner Lee E. Ponsky, MD. “The patient benefits with fewer biopsy-related complications and more accurate diagnosis and triaging of disease. We hope this study will provide sufficient evidence that will allow MRI prior to biopsy to be incorporated into management algorithms.”

    According to Dr. Gulani, prostate cancer diagnosis and treatment is quite primitive compared to other cancers. In 2017, clinicians still biopsy patients without a predetermined imaged based focus to target.

    “This is not true anywhere else in the body. We all operate from the assumption that the only real way we presently have of ‘seeing’ the cancer non-invasively—MRI—is not cost-effective for all comers,” Dr. Gulani said.

    Dr. Gulani and colleagues designed this study to test this assumption, and expected to find that obtaining an MRI before biopsy was not cost-effective.

    They developed a decision analysis model for biopsy-naive men recommended for a prostate biopsy based on abnormal digital rectal examination or elevated PSA levels. They evaluated three strategies: standard transrectal ultrasound guided biopsy, diagnostic MRI followed by MRI-targeted biopsy with no biopsy performed if MRI was negative, and diagnostic MRI followed by MRI-targeted biopsy with a standard biopsy performed when MRI was negative.

    “Ultrasound allows visualization of the prostate, but not direct visualization of a potential cancer. Transrectal ultrasound-guided biopsies involve the operator visualizing the prostate via a transrectal approach, and then obtaining a number of biopsies from the prostate by systematically sampling parts of the gland over multiple locations,” Dr. Gulani said.

    Next: Three MRI-guided biopsy strategies evaluated


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available